Pharma / Biotech

FDA Approves Imbruvica With Gazyva for First-Line CLL Treatment

The FDA expanded the labeling for Imbruvicato include use with Gazyva in treatment-naive patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.


Source link

Related posts

BUPROPION HYDROCHLORIDE Tablet, Film Coated [Cardinal Health]


LEVOFLOXACIN Tablet [NuCare Pharmaceuticals,Inc.]


Impact of obesity on the toxicity of a multi-ingredient dietary supplement, OxyELITE Pro™ (New Formula), using the novel NZO/HILtJ obese mouse model: Physiological and mechanistic assessments.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy